{
  "retracted": false,
  "timestamp": 1532563200000,
  "updates": [
    {
      "timestamp": 1584991937974,
      "identifier": {
        "doi": "10.1182/blood-2018-05-853192"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1182/blood-2017-05-780049"
  },
  "publisher": "American Society of Hematology",
  "title": "Pro B, Advani R, Brice P, et al. Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma. Blood. 2017;130(25):2709-2717."
}
